These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26679106)

  • 21. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
    El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
    Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches.
    Salo T; Vered M; Bello IO; Nyberg P; Bitu CC; Zlotogorski Hurvitz A; Dayan D
    Exp Cell Res; 2014 Jul; 325(2):58-64. PubMed ID: 24462456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.
    Deep G; Agarwal R
    Curr Cancer Drug Targets; 2013 Jun; 13(5):486-99. PubMed ID: 23617249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tumor microenvironment: promising therapeutic target].
    Kawasaki Y; Akiyama T
    Nihon Rinsho; 2015 Aug; 73(8):1283-7. PubMed ID: 26281679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target.
    Ocaña MC; Martínez-Poveda B; Quesada AR; Medina MÁ
    Med Res Rev; 2019 Jan; 39(1):70-113. PubMed ID: 29785785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of tumor microenvironment by chemopreventive natural products.
    Park SA; Surh YJ
    Ann N Y Acad Sci; 2017 Aug; 1401(1):65-74. PubMed ID: 28640929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
    Anari F; Ramamurthy C; Zibelman M
    Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasticity beyond cancer cells and the "immunosuppressive switch".
    Granot Z; Fridlender ZG
    Cancer Res; 2015 Nov; 75(21):4441-5. PubMed ID: 26475869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodal Molecular Imaging of the Tumour Microenvironment.
    Foray C; Barca C; Backhaus P; Schelhaas S; Winkeler A; Viel T; Schäfers M; Grauer O; Jacobs AH; Zinnhardt B
    Adv Exp Med Biol; 2020; 1225():71-87. PubMed ID: 32030648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex interplay between tumor microenvironment and cancer therapy.
    Shen M; Kang Y
    Front Med; 2018 Aug; 12(4):426-439. PubMed ID: 30097962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tumor microenvironment: part 1.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1367-84. PubMed ID: 22053887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Strategical consideration of the interaction between tumor microenvironment and tumor immunity].
    Fujiwara H
    Rinsho Ketsueki; 2018; 59(10):1895-1904. PubMed ID: 30305490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulating the tumor microenvironment with RNA interference as a cancer treatment strategy.
    Zins K; Sioud M; Aharinejad S; Lucas T; Abraham D
    Methods Mol Biol; 2015; 1218():143-61. PubMed ID: 25319650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
    Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
    Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tumour microenvironment: a novel target for cancer therapy.
    Hanna E; Quick J; Libutti SK
    Oral Dis; 2009 Jan; 15(1):8-17. PubMed ID: 18992016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Tumor Microenvironment for Cancer Therapy.
    Roma-Rodrigues C; Mendes R; Baptista PV; Fernandes AR
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mast cells as targets for immunotherapy of solid tumors.
    Oldford SA; Marshall JS
    Mol Immunol; 2015 Jan; 63(1):113-24. PubMed ID: 24698842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving radioresponse through modification of the tumor immunological microenvironment.
    Chi KH; Wang YS; Kao SJ
    Cancer Biother Radiopharm; 2012 Feb; 27(1):6-11. PubMed ID: 22239431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation in the tumor microenvironment.
    Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
    J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biological and clinical significance of stromal-epithelial interactions in breast cancer.
    McCuaig R; Wu F; Dunn J; Rao S; Dahlstrom JE
    Pathology; 2017 Feb; 49(2):133-140. PubMed ID: 28040198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.